Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Narcolepsy Industry By 2029?

The market size for narcolepsy has experienced a fast-paced expansion in the past few years. Forecasted to escalate from $3.56 billion in 2024 to $3.95 billion in 2025, the sector is predicted to achieve a compound annual growth rate (CAGR) of 10.9%. The unprecedented growth during the historical period is due to factors such as increased narcolepsy awareness, advancements and improvements in diagnostic equipment, debut of novel pharmacological therapies, investments in research and development, and robust patient education programs.

Anticipated rapid expansion is set to hit the narcolepsy market in the coming years. The market size is predicted to rocket to $5.96 billion by 2029, boasting a compound annual growth rate (CAGR) of 10.8%. Factors contributing to growth within the forecast period include an escalating incidence of sleep disorders, enhancements in healthcare infrastructure, encouraging government policies, a swelling elderly population, and heightened awareness of personal health among consumers. Forthcoming trends for the forecast period encompass progress in genetic research, technological breakthroughs in the diagnostic sector, the emergence of innovative drugs and treatment methods, strategic alliances and partnerships among foremost market players, and the use of digital health tools and telemedicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16491&type=smp

Which Industry Forces Are Driving The Narcolepsy Market Forward?

The increase in obese individuals is anticipated to fuel the expansion of the narcolepsy market. Classified as a health hazard, obesity is a medical disorder identified by an overabundance of body fat. The surge in obesity is attributed to more sedentary lifestyles, unhealthy dietary practices, and environmental elements that encourage the consumption of calorie-rich foods and diminish physical activity. Obesity can cause narcolepsy by interfering with metabolic and hormonal balances, possibly leading to alterations in sleep cycles and wakefulness regulation. For example, in March 2022, as per the World Health Organization, a specialized agency of the United Nations based in Switzerland with a mandate for global public health, close to 1 billion people, consisting of 650 million adults, 340 million adolescents, and 39 million children, were categorized as obese, and this number continues to rise. Forecasts show that by 2025, about 167 million adults and kids will experience health repercussions due to over-weight. Thus, the rising number of obese individuals is propelling the expansion of the narcolepsy market.

What Is The Segment Breakdown Of The Narcolepsy Market?

The narcolepsymarket covered in this report is segmented –

1) By Type: Type 1; Type 2

2) By Treatment: Antidepressants; Stimulants; Sodium Oxybate; Other Treatments

3) By Diagnosis: Polysomnogram; Multiple Sleep Latency Test

4) By End Users: Hospitals; Retail Pharmacies; Other End Users

Subsegments:

1) By Type 1: Stimulant Medications; Antidepressants; Sodium Oxybate; Immunosuppressive Treatments

2) By Type 2: Stimulant Medications; Sodium Oxybate; Antidepressants

How Are Global Trends Impacting The Development Of The Narcolepsy Market?

Significant entities in the narcolepsy market, like Avadel Pharmaceuticals plc, are honing in on the creation of innovative treatments such as extended-release sodium oxybate to meet the rising need for effective solutions. Extended-release sodium oxybate helps manage the symptoms of narcolepsy more effectively as it has a prolonged release feature, providing consistent relief from symptoms throughout the night, thereby enhancing sleep quality for those affected by the condition. An example of this is the launch of LUMRYZ by the Ireland-based pharmaceutical company, Avadel Pharmaceuticals plc, in the United States in June 2023. The FDA-approved LUMRYZ, an extended-release variant of sodium oxybate, is used to treat cataplexy or excessive daytime sleepiness (EDS) in adults suffering from narcolepsy. It holds the distinction of being the first and only oxybate medication that needs to be taken just once before bed, thereby providing a significant upgrade over other variants that require a second dosage at night.

Which Companies Are Contributing Significantly To The Narcolepsy Market Growth?

Major companies operating in the narcolepsy market are Pfizer Inc., Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Viatris Inc, Teva Pharmaceutical Industries, Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Ono Pharmaceutical Co. Ltd, Lupin Pharmaceuticals, Alkermes, Harmony Biosciences, Arena Pharmaceuticals, Cerevel Therapeutics, Axsome Therapeutics Inc., Avadel Pharmaceuticals, NLS Pharmaceutics AG, KemPharm, Suven Life Sciences Ltd

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/narcolepsy-global-market-report

Which Region Is Leading Innovation In The Narcolepsy Market?

North America was the largest region in the narcolepsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16491&type=smp

Browse Through More Reports Similar to the Global Narcolepsy Market 2025, By The Business Research Company

Narcotics Scanner Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/narcotics-scanner-global-market-report

Narcotic Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Narcotics Scanner Market 2025

https://www.thebusinessresearchcompany.com/report/narcotics-scanner-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model